KalVista Pharmaceuticals, Inc. (KALV)

Price & Market Data

Price: $26.73

Daily Change: +$0.02 / 0.07%

Daily Range: $26.68 - $26.74

Market Cap: $1,421,180,288

Daily Volume: 2,247,284

Performance Metrics

1 Week: 0.07%

1 Month: 36.45%

3 Months: 78.08%

6 Months: 148.0%

1 Year: 119.5%

YTD: 65.51%

About KalVista Pharmaceuticals, Inc. (KALV)

An in-depth look at KalVista Pharmaceuticals, Inc. (KALV). Current price: 26.73, daily change: +$0.02 / 0.07%. Market cap: 1,421,180,288. All key performance indicators for a thorough understanding.

Company Details

Employees: 275

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

KalVista Pharmaceuticals, Inc., a biopharmaceutical company, develops oral therapies for individuals for rare diseases with unmet needs. Its lead product candidate is EKTERLY, a fast-acting potent inhibitor of plasma kallikrein for the treatment of acute attacks of hereditary angioedema (HAE). The company is also developing is developing an orally disintegrating tablet formulation; KONFIDENT-KID for pediatric use with HAE; KONFIDENT; and KONFIDENT-S to evaluate sebetralstat and ODT formulation in adolescent and adult patients. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts.

Selected stocks

Brighthouse Financial, Inc. - depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN)

ProKidney Corp. (PROK)

FinWise Bancorp (FINW)

United Airlines Holdings, Inc. (UAL)

Key Tronic Corporation (KTCC)